Rizatriptan Benzoate

苯甲酸利扎曲普坦

Report date: 2026/05/24 20:00:34
NME

Base Information

Drug NameRizatriptan Benzoate
Drug Alias NameRizatriptanum苯甲酸利扎曲坦利扎曲普坦RizatriptanMaxalt-MLT +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1b (5-HT1b) receptor agonistsSerotonin 1d (5-HT1d) receptor agonists
TargetsSerotonin 1b (5-HT1b) receptorSerotonin 1d (5-HT1d) receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsMigraine Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMexico
Original Approved DateN/A
Country/TerritoryUnited StatesMexicoMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesARWAN Pharmaceuticals Industries Lebanon salChannel Therapeutics CorpGensco Laboratories LLC +[7] 
Inactive CompaniesOrganon & Co
Active IndicationsMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN02CC04
Related LinksWikipediaDrugBankKEGG